143526-61-8

Basic information

• Product Name: (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-12-{[tert-butyl(dimethyl)silyl]oxy}-5,21,23-trihydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl
• CAS NO: 143526-61-8
• Molecular Formula: C₄₉H₆₂N₂O₁₃Si
• Molecular Weight: 915.1077
• Mol File: 143526-61-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 949.856°C at 760 mmHg
• Flash Point: 528.254°C
• Density: 1.281g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.59
• CAS DataBase Reference: (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-12-{[tert-butyl(dimethyl)silyl]oxy}-5,21,23-trihydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-12-{[tert-butyl(dimethyl)silyl]oxy}-5,21,23-trihydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl(143526-61-8)
• EPA Substance Registry System: (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-12-{[tert-butyl(dimethyl)silyl]oxy}-5,21,23-trihydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl(143526-61-8)

Safety Data

• Hazardous Substances Data: 143526-61-8(Hazardous Substances Data)

Usage

General Description

The chemical "(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-12-{[tert-butyl(dimethyl)silyl]oxy}-5,21,23-trihydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl" is a complex organic compound with a highly intricate molecular structure. It consists of multiple hydroxyl groups, methyl groups, and a tert-butyl(dimethyl)silyl group. The chemical also contains a pentadeca[1,11,13]trienoazeno and a benzofuro[4,5-a]phenoxazin unit, as well as a 2,7-epoxy bond. It is a challenging molecule to synthesize and study due to its elaborate structure and the presence of multiple stereocenters.

Upstream product

• 62623-68-1 rifamycin S 
• 143526-60-7 2-amino-3-(tert-butyldimethylsilyloxy)phenol 
• 14897-39-3 monosodium rifamycin SV 
• 601-89-8 2-nitroresorcinol 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 634-60-6 2-aminoresorcinol hydrochloride 

Downstream Products

• 105396-59-6 ABI-1131 
• 129791-92-0 rifalazil 
• 129791-91-9 C₅₁H₆₄N₄O₁₃ 
• 148235-99-8 C₄₉H₆₀N₄O₁₃ 
• 143526-65-2 C₄₉H₆₀N₄O₁₃ 

Relevant articles and documents

Highly Efficient Synthesis of a Staphylococcus aureus Targeting Payload to Enable the First Antibody–Antibiotic Conjugate

A practical synthesis of the complex payload for an anti-Staphylococcus aureus THIOMABTM antibody–antibiotic conjugate (TAC) is described. The route takes advantage of a delicate oxidative condensation, achieved using a semi-continuous flow procedure. It allows for the generation of kilogram quantities of a key intermediate to enable a mild nucleophilic aromatic substitution to the tertiary amine free drug. The linker component is introduced as a benzylic chloride, which allows formation of the quaternary ammonium salt linker-drug. This chemical process surmounts numerous synthetic challenges and navigates deeply colored and unstable compounds to support clinical studies to counter S. aureus bacterial infections.

ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF

The invention provides rF1 antibody antibiotic conjugates and methods of using same.